Generic and therapeutic substitution: a response to our critic

Eating or Feeding Our Young: A Response to Recent Commentaries

Author's response to reviews Title:Inability to Achieve a Therapeutic Dose of Tacrolimus in a Pediatric Stem Cell Transplant Patient due to Generic Substitution Authors:

A critic-critic architecture to combine reinforcement and supervised learnings

In real life, learning is greatly speeded-up by the intervention of a teacher who gives examples, or shows, how to perform a certain task. In all this abstract, we let apart structural simpli cations of the problem by the designer which to not deal explicitely with learning. The intervention of the teacher can be realized in di erent ways: verbal explanation, demonstration, guidance, shaping th...

Generic substitution of antiepileptic drugs: What's a clinician to do?

Generic substitution of antiepileptic drugs remains a controversial area without a clear consensus to guide clinicians. The US Food and Drug Administration (FDA) requires rigorous testing of generic products and states that all approved products are interchangeable. FDA studies involve single doses in normal subjects so may not represent the performance of generic products in people with epilep...

Response to our critics.

Health Economics, Policy and Law / FirstView Article / January 2015, pp 1 9 DOI: 10.1017/S1744133114000590, Published online: 30 January 2015 Link to this article: http://journals.cambridge.org/abstract_S1744133114000590 How to cite this article: Alex Voorhoeve, Trygve Ottersen and Ole Fritjof Norheim Response to our critics. Health Economics, Policy and Law, Available on CJO 2015 doi:10.1017/S...